Jon T Willie1, Nealen G Laxpati, Daniel L Drane, Ashok Gowda, Christina Appin, Chunhai Hao, Daniel J Brat, Sandra L Helmers, Amit Saindane, Sherif G Nour, Robert E Gross. 1. Departments of *Neurosurgery, ‡Neurology, §Pathology, and ¶Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia; ‖Interventional MRI Program, Emory University Hospital, Atlanta, Georgia; #Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia; **Department of Neurology, University of Washington School of Medicine, Seattle, Washington; ††Visualase, Inc., Houston, Texas.
Abstract
BACKGROUND: Open surgery effectively treats mesial temporal lobe epilepsy, but carries the risk of neurocognitive deficits, which may be reduced with minimally invasive alternatives. OBJECTIVE: To describe technical and clinical outcomes of stereotactic laser amygdalohippocampotomy with real-time magnetic resonance thermal imaging guidance. METHODS: With patients under general anesthesia and using standard stereotactic methods, 13 adult patients with intractable mesial temporal lobe epilepsy (with and without mesial temporal sclerosis [MTS]) prospectively underwent insertion of a saline-cooled fiberoptic laser applicator in amygdalohippocampal structures from an occipital trajectory. Computer-controlled laser ablation was performed during continuous magnetic resonance thermal imaging followed by confirmatory contrast-enhanced anatomic imaging and volumetric reconstruction. Clinical outcomes were determined from seizure diaries. RESULTS: A mean 60% volume of the amygdalohippocampal complex was ablated in 13 patients (9 with MTS) undergoing 15 procedures. Median hospitalization was 1 day. With follow-up ranging from 5 to 26 months (median, 14 months), 77% (10/13) of patients achieved meaningful seizure reduction, of whom 54% (7/13) were free of disabling seizures. Of patients with preoperative MTS, 67% (6/9) achieved seizure freedom. All recurrences were observed before 6 months. Variances in ablation volume and length did not account for individual clinical outcomes. Although no complications of laser therapy itself were observed, 1 significant complication, a visual field defect, resulted from deviated insertion of a stereotactic aligning rod, which was corrected before ablation. CONCLUSION: Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy is a technically novel, safe, and effective alternative to open surgery. Further evaluation with larger cohorts over time is warranted.
BACKGROUND: Open surgery effectively treats mesial temporal lobe epilepsy, but carries the risk of neurocognitive deficits, which may be reduced with minimally invasive alternatives. OBJECTIVE: To describe technical and clinical outcomes of stereotactic laser amygdalohippocampotomy with real-time magnetic resonance thermal imaging guidance. METHODS: With patients under general anesthesia and using standard stereotactic methods, 13 adult patients with intractable mesial temporal lobe epilepsy (with and without mesial temporal sclerosis [MTS]) prospectively underwent insertion of a saline-cooled fiberoptic laser applicator in amygdalohippocampal structures from an occipital trajectory. Computer-controlled laser ablation was performed during continuous magnetic resonance thermal imaging followed by confirmatory contrast-enhanced anatomic imaging and volumetric reconstruction. Clinical outcomes were determined from seizure diaries. RESULTS: A mean 60% volume of the amygdalohippocampal complex was ablated in 13 patients (9 with MTS) undergoing 15 procedures. Median hospitalization was 1 day. With follow-up ranging from 5 to 26 months (median, 14 months), 77% (10/13) of patients achieved meaningful seizure reduction, of whom 54% (7/13) were free of disabling seizures. Of patients with preoperative MTS, 67% (6/9) achieved seizure freedom. All recurrences were observed before 6 months. Variances in ablation volume and length did not account for individual clinical outcomes. Although no complications of laser therapy itself were observed, 1 significant complication, a visual field defect, resulted from deviated insertion of a stereotactic aligning rod, which was corrected before ablation. CONCLUSION: Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy is a technically novel, safe, and effective alternative to open surgery. Further evaluation with larger cohorts over time is warranted.
Authors: Zdeněk Vojtěch; Lenka Krámská; Hana Malíková; Kateřina Seltenreichová; Tomáš Procházka; Miroslav Kalina; Roman Liščák Journal: Seizure Date: 2012-03-23 Impact factor: 3.184
Authors: Alexandre Carpentier; Roger J McNichols; R Jason Stafford; Jean-Pierre Guichard; Daniel Reizine; Suzette Delaloge; Eric Vicaut; Didier Payen; Ashok Gowda; Bernard George Journal: Lasers Surg Med Date: 2011-11-22 Impact factor: 4.025
Authors: Pinakin R Jethwa; Jason H Lee; Rachid Assina; Irwin A Keller; Shabbar F Danish Journal: J Neurosurg Pediatr Date: 2011-11 Impact factor: 2.375
Authors: Roger J McNichols; Ashok Gowda; Marko Kangasniemi; James A Bankson; Roger E Price; John D Hazle Journal: Lasers Surg Med Date: 2004 Impact factor: 4.025
Authors: Alexandre Carpentier; Roger J McNichols; R Jason Stafford; Julian Itzcovitz; Jean-Pierre Guichard; Daniel Reizine; Suzette Delaloge; Eric Vicaut; Didier Payen; Ashok Gowda; Bernard George Journal: Neurosurgery Date: 2008-07 Impact factor: 4.654
Authors: John P Andrews; Abhijeet Gummadavelli; Pue Farooque; Jennifer Bonito; Christopher Arencibia; Hal Blumenfeld; Dennis D Spencer Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302
Authors: Hepzibha Alexander; Kelsey Cobourn; Islam Fayed; Dewi Depositario-Cabacar; Robert F Keating; William D Gaillard; Chima O Oluigbo Journal: Childs Nerv Syst Date: 2019-01-09 Impact factor: 1.475
Authors: Walter J Jermakowicz; Andres M Kanner; Samir Sur; Christina Bermudez; Pierre-Francois D'Haese; John Paul G Kolcun; Iahn Cajigas; Rui Li; Carlos Millan; Ramses Ribot; Enrique A Serrano; Naymee Velez; Merredith R Lowe; Gustavo J Rey; Jonathan R Jagid Journal: Epilepsia Date: 2017-02-28 Impact factor: 5.864
Authors: Chengyuan Wu; Michael J LaRiviere; Nealen Laxpati; James J Evans; Robert E Gross; Ashwini D Sharan Journal: Neurosurgery Date: 2014-06 Impact factor: 4.654